{{Rsnum
|rsid=11672691
|Gene=SLC26A6
|Chromosome=19
|position=41479679
|Orientation=plus
|GMAF=0.449
|Gene_s=SLC26A6
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}[[rs11672691]] is a SNP on chromosome 19 located between the [[ATP5SL]] and [[CEACAM21]] genes and within LOC100505495, a possible noncoding RNA.{{PMID|23065704}}

A large study of over 10,000 patients with [[prostate cancer]] concluded that each [[rs11672691]](G) allele was associated with an increased risk (by 1.18x) of prostate cancer specific mortality (PCSM), i.e. death from the cancer.{{PMID|24411283}}

A meta-analysis of 4 studies totaling ~6000 patients with [[prostate cancer]] and follow up in 49,000 samples concluded that [[rs11672691]] was associated with increased susceptibility (odds ratio 1.12, CI:1.03–1.21, p = 1.4 x 10e-8) but also with aggressive prostate cancer and therefore a poorer prognosis.{{PMID|23065704}}

{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 7.1 | 41.6 | 51.3
| HCB | 13.1 | 43.8 | 43.1
| JPT | 25.7 | 47.8 | 26.5
| YRI | 81.6 | 17.7 | 0.7
| ASW | 66.1 | 26.8 | 7.1
| CHB | 13.1 | 43.8 | 43.1
| CHD | 11.9 | 48.6 | 39.4
| GIH | 11.9 | 41.6 | 46.5
| LWK | 88.2 | 10.9 | 0.9
| MEX | 3.4 | 50.0 | 46.6
| MKK | 67.9 | 30.8 | 1.3
| TSI | 3.9 | 34.3 | 61.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23065704
  |Trait=Prostate cancer
  |Title=A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.
  |RiskAllele=G
  |Pval=1E-8
  |OR=1.11
  |ORtxt=[1.02-1.20]
  |OA=1
}}


{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}